Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis;Bedeutung von adrenomedullin in der pathogenese und behandlung kardiovaskulärer dysfunktionen und der sepsis

Anaesthesist

Volumn 55, Issue 2, 2006, Pages 171-178

  Westphal, M ^a   Sander, J ^a   Van Aken, H ^a   Ertmer, C ^a   Stubbe, H D ^a   Booke, M ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Klinikum des Main Taunus   (Germany)

Author keywords

Adrenomedullin; Multiple organ failure; Oxygen transport; Pulmonary hypertension; Sepsis

Indexed keywords

ADRENOMEDULLIN; PEPTIDE HORMONE; PEPTIDE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONGESTIVE HEART FAILURE; DRUG POTENCY; HEART HEMODYNAMICS; HEART INFARCTION; HORMONE ACTION; HYPERTENSION; LUNG FUNCTION; MICROANGIOPATHY; PATHOGENESIS; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; SEPSIS; SEPTIC SHOCK; AMINO ACID SEQUENCE; DRUG EFFECT; HEMODYNAMICS; HOMEOSTASIS; HUMAN; METABOLISM; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADRENOMEDULLIN; AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASES; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; SEPSIS; SIGNAL TRANSDUCTION;

EID: 33344475585     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-005-0888-0     Document Type: Review

References (66)

1. Allaker RP, Zihni C, Kapas S (1999) An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 23(4):289-293
2. Bene R del, Lazzeri C, Barletta G, Vecchiarino S, Guerra CT, Franchi F, Villa G la (2000) Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man. Clin Physiol 20(6):457-465
3. Bone HG, Sielenkamper A, Booke M (1999) Sauerstoffangebot in der Sepsis. Seit 10 Jahren mehr Fragen als Antworten. Anaesthesist 48(2):63-79
4. Born W, Muff R, Fischer JA (2002) Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP). Microsc Res Tech 57(1):14-22
5. Cockcroft JR, Noon JP, Gardner-Medwin J, Bennett T (1997) Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. Br J Clin Pharmacol 44(1):57-60
6. Elsasser TH, Kahl S (2002) Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Tech 57(2):120-129
7. Elsasser TH, Kahl S, Martinez A, Montuenga LM, Pio R, Cuttitta F (1999) Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinology 140(10):4908-4911
8. Fowler D, Wang P (2002) The cardiovascular response in sepsis: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein, Int J Mol Med 9(5):443-449
9. Grimminger F, Seeger W (1997) Sepsis. In: Lasch HG, Lenz K, Seeger W (Hrsg) Lehrbuch der Internistischen Intensivtherapie, 3. Aufl. Schattauer, Stuttgart, S 627-650
10. Grocott-Mason RM, Sha AM (1998) Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive Care Med 24(4):286-295
11. Hardt K von der, Kandler MA, Chada M et al. (2004) Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure. Eur Respir J 24(4):615-623
12. Hattori Y, Nakanishi N, Gross SS, Kasai K (1999) Adrenomedullin augments nitric oxide and tetrahydrobioptein synthesis in cytokine-stimulated vascular smooth muscle cells. Cardiovasc Res 44(1):207-214
13. Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21(2):138-167
14. Horio T, Nishikimi T, Yoshihara F, Nagaya N, Matsuo H, Takishita S, Kangawa K (1998) Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1beta and tumor necrosis factor-alpha. Endocrinology 139(11):4576-4580
15. Kakishita M, Nishikimi T, Okano Y et al. (1999) Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci 96(1):33-39
16. Kamoi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otani S (1995) Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 211(3):1031-1035
17. Kandler MA, Hardt K von der, Mahfoud S et al. (2003) Pilot Intervention: aerosolized adrenomedullin reduces pulmonary hypertension. J Pharmacol Exp Ther 306(3):1021-1026
18. Kitamura K, Eto T (1997) Adrenomedullin - Physiological regulator of the cardiovascular system or biochemical curiosity? Curr Opin Nephrol Hypertens 6(1):80-87
19. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192(2)553-560
20. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T (1993) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194(2):720-725
21. Kitamura K, Kangawa K, Eto T (2002) Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 57(1):3-13
22. Kobayashi K, Kitamura K, Etoh T et al. (1996) Increased plasma adrenomedullin levels in chronic congestive heart failure. Am Heart J 131(5):994-998
23. Kohno M, Hanehira T, Kano H et al. (1996) Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27(1):102-107
24. Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, Wang P (2000) Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 91(1):70-76
25. Kubo A, Minamino N, Isumi Y, Katafuchi T, Kangawa K, Dohi K, Matsuo H (1998) Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 273(27):16730-16738
26. Mallamaci F, Zoccali C, Parlongo S, Cutrupi S, Tripepi G, Postorino M (1998) Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients. Kidney Int 54(5):1697-1703
27. Martinez A, Elsasser TH, Muro-Cacho C, Moody TW, Miller MJ, Macri CJ, Cuttitta F (1997) Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138(12)5597-5604
28. Marutsuka K, Nawa Y, Asada Y, Hara S, Kitamura K, Eto T, Sumiyoshi A (2001) Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol 86(5):543-545
29. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR (1997) Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 82(1):95-100
30. Mori Y, Nishikimi T, Kobayashi N, Ono H, Kangawa K, Matsuoka H (2002) Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension 40(1):107-113
31. Nagaya N, Nishikimi T, Horio T, Yoshihara F, Kanazawa A, Matsuo H, Kangawa K (1999) Cardiovascular and renal effects of adrenomedullin in rats with heart failure. Am J Physiol 276:R213-218
32. Nagaya N, Nishikimi T, Uematsu M et al. (2000) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 84(6):653-658
33. Nagaya N, Satoh T, Nishikimi T et al. (2000) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101(5):498-503
34. Nagaya N, Goto Y, Satoh T, Sumida H, Kojima S, Miyatake K, Kangawa K (2002) Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 39(5):754-760
35. Nagaya N, Kyotani S, Uematsu M et al. (2004) Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation 109(3):351-356
36. Nakamura R, Kato J, Kitamura K, Onitsuka H, Imamura T, Marutsuka K, Asada Y (2002) Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res 56(3):373-380
37. Nishio K, Akai Y, Murao Y et al. (1997) Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 25(6):953-957
38. Ono Y, Kojima M, Okada K, Kangawa K (1998) cDNA cloning of canine adrenomedullin and its gene expression in the heart and blood vessels in endotoxin shock. Shock 10(4):243-247
39. Ornan DA, Chaudry IH, Wang P (1999) Pulmonary clearance of adrenomedullin is reduced during the late stage of sepsis. Biochim Biophys Acta 1427(2):315-321
40. Ornan DA, Chaudry IH, Wang P (2002) Saturation of adrenomedullin receptors plays an important role in reducing pulmonary clearance of adrenomedullin during the late stage of sepsis. Biochim Biophys Acta 1586(3):299-306
41. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328(20):1471-1477
42. Paterson RL, Webster NR (2000) Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb 45(3):178-182
43. Pio R, Martinez A, Unsworth EJ et al. (2001) Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276(15):12292-12300
44. Pio R, Elsasser TH, Martinez A (2002) Identification, characterization, and physiological actions of factor H as an adrenomedullin binding protein present in human plasma. Microsc Res Tech 57(1):23-27
45. Rademaker MT, Charles CJ, Lewis LK et al. (1997) Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96(6):1983-1990
46. Rademaker MT, Charles CJ, Cooper GJS et al. (2002) Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. Clin Sci 102(6):653-660
47. Rademaker MT, Charles CJ, Cooper GJS et al. (2002) Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure. Hypertension 39(1):93-98
48. Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM (2002) Long-term adrenomedullin administration in experimental heart failure. Hypertension 40(5):667-672
49. Sakai K, Saito K, Ishizuka N (1998) Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels. Eur J Pharmacol 359(2-3):151-159
50. So S, Hattori Y, Kasai K, Shimoda S, Gross SS (1996) Up-regulation of rat adrenomedullin gene expression by endotoxin: relation to nitric oxide synthesis. Life Sci 58(19):PL309-315
51. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H (1995) Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 207(1):25-32
52. Taylor MM, Samson WK (2002) Adrenomedullin and the integrative physiology of fluid and electrolyte balance. Microsc Res Tech 57(2):105-109
53. Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG (2000) Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 36(4)588-593
54. Ueda S, Nishio K, Minamino N et al. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 160(1):132-136
55. Vijay P (2000) Adrenomedullin in the treatment of pulmonary hypertension. Heart 84(6):575-576
56. Wang P, Ba ZF, Cioffi WG, Bland KI, Chaudry IH (1998) The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg 133(12):1298-1304
57. Wang P, Yoo P, Zhou M, Cioffi WG, Ba ZF, Chaudry IH (1999) Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 85(1)59-65
58. Westphal M, Stubbe H, Bone HG, Daudel F, Vocke S, Aken H van, Booke M (2002) Hemodynamic effects of exogenous adrenomedullin in healthy and endotoxemic sheep. Biochem Biophys Res Commun 296(1):134-138
59. Westphal M, Booke M, Dinh-Xuan AT (2004) Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension. Eur Respir J 24(4)518-520
60. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL (1996) Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol 28(3):458-462
61. Yang S, Zhou M, Chaudry IH, Wang P (2001) The role of lipopolysaccharide in stimulating adrenomedullin production during polymicrobial sepsis. Biochim Biophys Acta 1537(2):167-174
62. Yang S, Zhou M, Chaudry IH, Wang P (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg 236(5):625-633
63. Yang S, Zhou M, Fowler DE, Wang P (2002) Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: down-regulation of proinflammatory cytokines. Crit Care Med 30(12):2729-2735
64. Zhou M, Chaudry IH, Wang P (1999) Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis. Biochim Biophys Acta 1453(2):273-283
65. Zhou M, Chaudry IH, Wang P (2001) The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am J Physiol Regul Integr Comp Physiol 281(2):R654-660
66. Zhou M, Ba ZF, Chaudry IH, Wang P (2002) Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am J Physiol Regul Integr Comp Physiol 283(3):R553-560